Search results
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 1 day agoMerck (NYSE:MRK) First Quarter 2024 Results Key Financial Results Revenue: US$15.8b (up 8.9% from 1Q...
Is Merck Stock Fully Valued At $130?
Forbes· 6 days agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 4 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
Zacks via Yahoo Finance· 3 hours agoThe top 10 holdings account for about 16.51% of total assets under management. Performance and Risk...
3 Pharma Stocks With the Potential to Make You an Overnight Millionaire
InvestorPlace via Yahoo Finance· 6 days agoPharmaceutical corporations have long been significant drivers in improving and impacting modern...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters· 1 day agoGossamer Bio said on Monday it will collaborate with Italian drugmaker Chiesi Group to develop and...
15 Best Places to Retire in Florida That You’ve Never Heard Of
Insider Monkey via Yahoo Finance· 6 days agoThis article takes a look at the 15 best places to retire in Florida that you’ve never heard of. If...
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha· 5 days agoPrivately held Cerevance receives milestone payment from Merck for Alzheimer's research...
Futures: Stocks Extend Gains; Apple Event Next
Investor's Business Daily· 16 hours agoKey earnings movers late Monday include Palantir, Axon and Vertex Pharmaceuticals.